We are live on ! Find out more
GMDA

Gamida Cell Ltd. Ordinary Shares
GMDA

Delisted

GMDA was delisted on the 5th of April, 2024.

Back to rankings

70 hedge funds and large institutions have $157M invested in Gamida Cell Ltd. Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $1.14M | Put options by funds: $707K

0% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 19

4% less funds holding

Funds holding: 73 → 70 (-3)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

24% less capital invested

Capital invested by funds: $206M → $157M (-$49.3M)

Holders
70
Holders Change
-3
Holders Change %
-4.11%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
19
Reduced
19
Closed
17
Calls
$1.14M
Puts
$707K
Net Calls
+$433K
Net Calls Change
-$1.3M

Top Buyers

Rank Fund Capital Flow
1
LNWTC
Laird Norton Wetherby Trust Company
Washington
+$3.65M
2
SCM
Stonepine Capital Management
Oregon
+$1.37M
3
Mariner
Mariner
Kansas
+$1.11M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$961K
5
Renaissance Technologies
Renaissance Technologies
New York
+$949K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.6M
2
CCM
Consonance Capital Management
New York
-$3.17M
3
BBA
Baker Bros. Advisors
New York
-$2.94M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.93M
5
SFM
Sphera Funds Management
Israel
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
HVC
26
Healthcare Value Capital
New Jersey
$481K +$172K +25,000 +50%
Morgan Stanley
27
Morgan Stanley
New York
$465K +$302K +43,794 +152%
Two Sigma Investments
28
Two Sigma Investments
New York
$401K +$431K +62,587 New
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$338K +$363K +52,690 New
Two Sigma Advisers
30
Two Sigma Advisers
New York
$326K +$89.6K +13,000 +34%
PTP
31
Platform Technology Partners
New York
$291K +$313K +45,375 New
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
$263K +$173K +25,071 +156%
Citadel Advisors
33
Citadel Advisors
Florida
$254K -$51.3K -7,440 -16%
VEA
34
Virtus ETF Advisers
New York
$223K +$12.4K +1,800 +5%
IC
35
Ikarian Capital
Texas
$201K -$724K -104,976 -77%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$200K – – –
JF
37
Jump Financial
Illinois
$183K +$54.6K +7,926 +38%
State Street
38
State Street
Massachusetts
$172K -$4.34K -630 -2%
Goldman Sachs
39
Goldman Sachs
New York
$155K -$50.4K -7,313 -23%
CSS
40
Cubist Systematic Strategies
Connecticut
$139K -$98.1K -14,227 -40%
ML
41
McAdam LLC
Pennsylvania
$129K – – –
UBS Group
42
UBS Group
Switzerland
$101K +$35.1K +5,087 +48%
TI
43
Trexquant Investment
Connecticut
$90K +$96.3K +13,969 New
XT
44
XTX Topco
Cayman Islands
$84K +$90.6K +13,141 New
ECM
45
ExodusPoint Capital Management
New York
$81K +$86.9K +12,600 New
Northern Trust
46
Northern Trust
Illinois
$80K -$59.7K -8,662 -41%
OC
47
Oppenheimer & Co
New York
$69K – – –
ProShare Advisors
48
ProShare Advisors
Maryland
$68K +$73.3K +10,637 New
VWM
49
Vigilare Wealth Management
Arizona
$64K -$13.8K -2,000 -17%
1CM
50
1492 Capital Management
Wisconsin
$64K – – –
1
2
3 4

GMDA Hedge Fund Activity: Q2 2021 in Review

70 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q2 2021, worth a combined $157M — down 24% from $206M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of GMDA and 14 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 19 added.

The largest buyer was Laird Norton Wetherby Trust Company, opening a new position worth an estimated $3.65M. The largest seller was Fidelity Investments, cutting an estimated $3.6M.

  • 70 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q2 2021, down from 73 in Q1 2021.
  • Funds reported $157M of Gamida Cell Ltd. Ordinary Shares stock for Q2 2021, down 24% quarter-over-quarter.
  • 14 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q2 2021 and 17 closed out, a net change of -3 holders.
  • The largest Gamida Cell Ltd. Ordinary Shares buyer in Q2 2021 was Laird Norton Wetherby Trust Company, an estimated $3.65M added.
  • The largest Gamida Cell Ltd. Ordinary Shares seller in Q2 2021 was Fidelity Investments, an estimated $3.6M sold.

Based on aggregated 13F filings for Q2 2021.